200 related articles for article (PubMed ID: 31623897)
21. [Clinical analysis of 132 cases of cervical adenosquamous carcinoma and cervical adenocarcinoma].
Meng YH; Li S; Hu T; Ma D; Lu YP; Wang H
Chin J Cancer; 2010 Jan; 29(1):15-9. PubMed ID: 20038304
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: a retrospective study.
Zhang H; Yu R; Zhang L; Wang R; Xiao L
BMC Cancer; 2022 Feb; 22(1):202. PubMed ID: 35193525
[TBL] [Abstract][Full Text] [Related]
23. Postoperative adjuvant therapy in early invasive cervical cancer patients with histopathologic high-risk factors.
Park TK; Kim SN; Kwon JY; Mo HJ
Int J Gynecol Cancer; 2001; 11(6):475-82. PubMed ID: 11906552
[TBL] [Abstract][Full Text] [Related]
24. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
25. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
[TBL] [Abstract][Full Text] [Related]
26. Preoperative prognostic factors and effects of adjuvant therapy on outcomes of early stage cervical cancer in Iran.
Behtash N; Karimi Zarchi M; Deldar M
Asian Pac J Cancer Prev; 2009; 10(4):613-8. PubMed ID: 19827880
[TBL] [Abstract][Full Text] [Related]
27. [Trend in proportion and clinicopathological characteristics of young women with stage Ⅰa2 to Ⅱa2 cervical cancer].
Wang W; Hao M; Chen CL; Liu P; Ling B; Kang S; Lu AW; Wang WL; Zhao WD; Zhu QY; Zhao YY; Zhao HW; Jin SL; Ni Y; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):666-672. PubMed ID: 31648442
[No Abstract] [Full Text] [Related]
28. Clinical and pathological characteristics related to parametrial involvement in clinical early-stage cervical cancer.
Boyraz G; Basaran D; Salman MC; Ozgul N; Yuce K
Ginekol Pol; 2016; 87(6):417-21. PubMed ID: 27418217
[TBL] [Abstract][Full Text] [Related]
29. Outcome of patients with incomplete resection after surgery for stage IB2/II cervical carcinoma with chemoradiation therapy.
Uzan C; Vincens E; Balleyguier C; Gouy S; Pautier P; Duvillard P; Haie-Meder C; Morice P
Int J Gynecol Cancer; 2010 Apr; 20(3):379-84. PubMed ID: 20375801
[TBL] [Abstract][Full Text] [Related]
30. A Predictive Model for Parametrial Invasion in Patients With FIGO Stage IB Cervical Cancer: Individualized Approach for Primary Treatment.
Kong TW; Piao X; Chang SJ; Paek J; Lee Y; Lee EJ; Ryu HS
Int J Gynecol Cancer; 2016 Jan; 26(1):184-91. PubMed ID: 26512782
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
Park SH; Cheon H; Chong GO; Jeong SY; Lee JE; Kang MK; Kim MY; Lee JW; Park J; Kim JC
Gynecol Oncol; 2018 Mar; 148(3):449-455. PubMed ID: 29329882
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor in cervical carcinoma.
Cheng WF; Chen CA; Lee CN; Chen TM; Hsieh FJ; Hsieh CY
Obstet Gynecol; 1999 May; 93(5 Pt 1):761-5. PubMed ID: 10912982
[TBL] [Abstract][Full Text] [Related]
33. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
35. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma.
Sakuragi N; Takeda N; Hareyama H; Fujimoto T; Todo Y; Okamoto K; Takeda M; Wada Si; Yamamoto R; Fujimoto S
Cancer; 2000 Jun; 88(11):2578-83. PubMed ID: 10861436
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
37. Influence of lymph vascular space invasion on prognosis of patients with early-stage cervical squamous cell carcinoma.
Yan M; Zhang YN; He JH; Sun JR; Sun XM
Chin J Cancer; 2010 Apr; 29(4):425-30. PubMed ID: 20346220
[TBL] [Abstract][Full Text] [Related]
38. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
39. Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.
Trifiletti DM; Swisher-McClure S; Showalter TN; Hegarty SE; Grover S
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1032-44. PubMed ID: 26581141
[TBL] [Abstract][Full Text] [Related]
40. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]